Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1953 1
1958 1
1962 1
1963 1
1964 1
1967 2
1969 5
1970 5
1971 1
1972 1
1976 1
1977 1
1979 2
1980 1
1981 4
1982 2
1983 2
1984 10
1985 16
1986 18
1987 9
1988 18
1989 21
1990 17
1991 29
1992 18
1993 21
1994 20
1995 33
1996 20
1997 14
1998 10
1999 14
2000 17
2001 23
2002 26
2003 27
2004 23
2005 26
2006 21
2007 27
2008 21
2009 16
2010 26
2011 24
2012 37
2013 30
2014 33
2015 33
2016 33
2017 33
2018 32
2019 41
2020 34
2021 33
2022 35
2023 26
2024 44
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

973 results

Results by year

Filters applied: . Clear all
Page 1
Real-world comparative study of the efficacy of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.
Hayashi S, Tachibana S, Maeda T, Yamashita M, Shirasugi I, Yamamoto Y, Yamada H, Okano T, Nishimura K, Ueda Y, Jinno S, Saegusa J, Yamamoto W, Murata K, Fujii T, Hata K, Yoshikawa A, Ebina K, Etani Y, Yoshida N, Amuro H, Hashimoto M, Hara R, Katayama M, Okano T, Kuroda R. Hayashi S, et al. Among authors: katayama m. Rheumatology (Oxford). 2024 Nov 1;63(11):3033-3041. doi: 10.1093/rheumatology/kead543. Rheumatology (Oxford). 2024. PMID: 37924201
Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort study.
Jinno S, Onishi A, Hattori S, Dubreuil M, Ueda Y, Nishimura K, Okano T, Yamada H, Yamamoto W, Murata K, Onizawa H, Ebina K, Maeda Y, Son Y, Amuro H, Hara R, Hata K, Shiba H, Katayama M, Watanabe R, Hashimoto M, Saegusa J. Jinno S, et al. Among authors: katayama m. Rheumatology (Oxford). 2024 Feb 6:keae081. doi: 10.1093/rheumatology/keae081. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38317442
Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.
Nakayama Y, Watanabe R, Murakami K, Murata K, Tanaka M, Ito H, Yamamoto W, Ebina K, Hata K, Hiramatsu Y, Katayama M, Son Y, Amuro H, Akashi K, Onishi A, Hara R, Yamamoto K, Ohmura K, Matsuda S, Morinobu A, Hashimoto M. Nakayama Y, et al. Among authors: katayama m. Rheumatol Int. 2022 Jul;42(7):1227-1234. doi: 10.1007/s00296-021-05086-w. Epub 2022 Mar 10. Rheumatol Int. 2022. PMID: 35266034
Association of large joint involvement at the start of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort study.
Shirasugi I, Onishi A, Nishimura K, Yamamoto W, Murakami K, Onizawa H, Maeda Y, Ebina K, Son Y, Amuro H, Katayama M, Hara R, Nagai K, Hiramatsu Y, Hashimoto M, Okano T, Maeda T, Hayashi S, Sendo S, Jinno S, Yamamoto Y, Yamada H, Ueda Y, Saegusa J. Shirasugi I, et al. Among authors: katayama m. Int J Rheum Dis. 2024 Mar;27(3):e15097. doi: 10.1111/1756-185X.15097. Int J Rheum Dis. 2024. PMID: 38439176
Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium.
Eng JW, Kato Y, Adachi Y, Swaminathan B, Naiche LA, Vadakath R, Sakamoto Y, Nakazawa Y, Tachino S, Ito K, Abe T, Minoshima Y, Hoshino-Negishi K, Ogasawara H, Kawakatsu T, Nishimura M, Katayama M, Shimizu M, Tahara K, Sato T, Suzuki K, Agarwala K, Iwata M, Nomoto K, Ozawa Y, Imai T, Funahashi Y, Matsui J, Kitajewski J. Eng JW, et al. Among authors: katayama m. Cancer Res Commun. 2024 Jul 1;4(7):1881-1893. doi: 10.1158/2767-9764.CRC-24-0081. Cancer Res Commun. 2024. PMID: 38984877 Free PMC article.
[Psittacosis].
Katayama M. Katayama M. Ryoikibetsu Shokogun Shirizu. 1999;(24 Pt 2):226-9. Ryoikibetsu Shokogun Shirizu. 1999. PMID: 10201182 Review. Japanese. No abstract available.
Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.
Ebina K, Hirano T, Maeda Y, Yamamoto W, Hashimoto M, Murata K, Onishi A, Jinno S, Hara R, Son Y, Amuro H, Takeuchi T, Yoshikawa A, Katayama M, Yamamoto K, Okita Y, Hirao M, Etani Y, Kumanogoh A, Okada S, Nakata K. Ebina K, et al. Among authors: katayama m. Sci Rep. 2022 Jan 7;12(1):134. doi: 10.1038/s41598-021-04075-0. Sci Rep. 2022. PMID: 34997059 Free PMC article.
Nivolumab in Patients with Metastatic Castration-Resistant Prostate Cancer with and without DNA Repair Defects.
Isaacsson Velho P, Bastos DA, Saint'ana PT, Rigatti B, da Costa ET, Muniz DQB, Andreis F, Ferreira RDP, Giongo Pedrotti L, Maistro S, Katayama MLH, Folgueira MAAK, Morelle A, Leal A, de Castro G Jr. Isaacsson Velho P, et al. Among authors: katayama mlh. Clin Cancer Res. 2024 Dec 2;30(23):5342-5352. doi: 10.1158/1078-0432.CCR-24-1595. Clin Cancer Res. 2024. PMID: 39330991 Clinical Trial.
973 results